Healthcare Economics

Cost of Healthcare Cost Management Insurance Economics Cost of Care Insurance Market Cost-Benefit Analysis Cost Analysis Drug Pricing Insurance Premiums Pharmaceutical Industry

CMS Unveils Voluntary BALANCE Program to Lower GLP-1 Costs for Medicare and Medicaid

The program pairs discounted drug access with no-cost lifestyle support through a phased rollout beginning in 2026.

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

White House Secures Nine More Drugmaker Pacts on MFN Pricing as TrumpRx Nears Launch

Trump Adds Nine Pharma Giants to Drug Pricing Deals, Reaching 14 Signatories as TrumpRx Nears Launch

ChristianaCare and Virtua Health Call Off Merger, Remain Independent

Medicare’s First Negotiated Drug Prices Take Effect Jan. 1, Cutting 2026 Costs

China to Eliminate Out-of-Pocket Childbirth Costs Nationwide by 2026

France’s Private Doctors Keep January Strike Call, Plan Paris Protest

House Oversight Hearing Weighs Tech Fixes for Soaring Health Costs

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

UK Cuts NHS Rebate on New Branded Drugs to 14.5% for 2026 Under US Trade Framework

Nursing Excluded From Higher Loan Limits in Draft Federal Rule, Drawing Pushback

New York Fed Survey Shows Financial Strain as Inflation Expectations Stay Elevated

Daily Pantoprazole Cuts ICU Bleeding and Hospital Costs, JAMA Study Finds

ACA Subsidy Cliff Nears as Senate Sets December Vote and GOP Divisions Complicate Path

Medicare Sets 2027 Prices for 15 High-Cost Drugs, Including Ozempic

Japan Backs Fifth Straight Rise in National Health Insurance Cap for FY2026

Delhi Opens 70 Ayushman Arogya Mandirs, Taking Operational Total to 238

MOH Overhauls Integrated Shield Riders: No Deductible Coverage and S$6,000 Co-Pay Cap From April 2026

Argentina’s Pediatric Society Warns of Steep Fall in Childhood Vaccination